West German Study Group   Report issue

Foundation Phase 2 Phase 3
Founded: Dusseldorf Germany (1994)

Organization Overview

First Clinical Trial
2000
NCT02115204
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Westdeutsche Studiengruppe GmbH | West German Study Group